Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
600267 Zhejiang Hisun Pharmaceutical
- 8.76
- +0.08+0.92%
Not Open Dec 12 15:00 CST
10.58BMarket Cap-515.29P/E (TTM)
8.77High8.60Low136.35KlotVolume8.66Open8.68Pre Close118.91MTurnover1.14%Turnover RatioLossP/E (Static)1.21BShares9.8452wk High1.28P/B10.50BFloat Cap6.4352wk Low9.55Limit Up1.20BShs Float27.24Historical High7.81Limit Down1.96%Amplitude1.42Historical Low--Dividend TTM8.72Avg Price62.98KlotAsk--Div YieldTTM100Lot Size71.67KlotBid
Zhejiang Hisun Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -9.50%7.87B | -13.48%5.24B | -11.00%2.73B | -13.82%10.37B | -0.49%8.7B | 5.64%6.06B | 2.90%3.06B | -0.82%12.04B | -3.99%8.74B | -4.46%5.74B |
| Operating revenue | -9.50%7.87B | -13.48%5.24B | -11.00%2.73B | -13.82%10.37B | -0.49%8.7B | 5.64%6.06B | 2.90%3.06B | -0.82%12.04B | -3.99%8.74B | -4.46%5.74B |
| Other operating revenue | ---- | -20.06%102.82M | ---- | -34.32%215.53M | ---- | 21.55%128.62M | ---- | 40.19%328.14M | ---- | 9.49%105.82M |
| Total operating cost | -9.75%7.32B | -11.80%4.91B | -7.20%2.58B | -9.96%10.13B | -0.61%8.11B | 2.98%5.56B | 0.15%2.78B | -2.06%11.26B | -5.36%8.17B | -3.87%5.4B |
| Operating cost | -9.31%4.63B | -10.23%3.18B | -4.91%1.74B | -11.57%6.19B | -0.96%5.11B | 3.18%3.54B | 1.33%1.83B | -2.61%7B | -4.77%5.16B | -3.28%3.43B |
| Operating tax surcharges | 28.90%77.05M | 33.08%43.92M | 13.23%26.91M | -20.83%84.94M | -17.85%59.77M | -26.59%33M | -21.72%23.77M | -0.49%107.3M | -14.65%72.76M | -11.86%44.96M |
| Operating expense | -12.26%1.58B | -19.14%999.87M | -14.21%470.41M | -1.57%2.37B | 4.82%1.8B | 10.80%1.24B | 2.01%548.32M | -3.68%2.41B | -8.74%1.72B | -8.97%1.12B |
| Administration expense | -2.35%667.22M | -1.17%434.58M | -4.34%212.74M | -13.64%908.67M | -6.67%683.26M | -9.88%439.72M | -7.93%222.39M | 5.62%1.05B | 2.94%732.08M | 8.77%487.91M |
| Financial expense | -31.83%101.4M | -29.21%72.53M | -32.11%37.95M | -27.05%191.67M | -23.99%148.74M | -26.90%102.46M | -24.90%55.89M | -20.68%262.75M | -26.29%195.69M | -24.59%140.16M |
| -Interest expense (Financial expense) | -26.01%123.27M | -23.57%87.51M | -17.17%46.82M | -23.92%215.4M | -24.05%166.6M | -26.03%114.5M | -26.69%56.52M | -18.13%283.12M | -18.35%219.37M | -17.26%154.8M |
| -Interest Income (Financial expense) | -18.15%-20.27M | -39.49%-15.03M | -93.27%-9.68M | 12.60%-23.17M | 9.85%-17.15M | 13.67%-10.78M | -39.11%-5.01M | -22.22%-26.51M | -30.61%-19.03M | -18.73%-12.48M |
| Research and development | -15.65%262.63M | -15.74%177.55M | -8.10%89.18M | -8.57%391.95M | 8.72%311.38M | 16.13%210.71M | 16.52%97.04M | 14.99%428.69M | 8.30%286.4M | 13.01%181.44M |
| Credit Impairment Loss | 32.45%-15.11M | 33.06%-20.32M | 88.80%-2.2M | -346.47%-23.48M | 47.00%-22.37M | -131.09%-30.36M | -256.14%-19.64M | 175.02%9.53M | -19.37%-42.2M | -3.25%-13.14M |
| Asset Impairment Loss | -123.19%-186.77M | 14.05%-72.74M | -81.34%-32.27M | -126.54%-285.52M | -28.15%-83.68M | -176.00%-84.63M | 38.68%-17.8M | -15.17%-126.04M | 14.91%-65.3M | 51.62%-30.66M |
| Other net revenue | 115.92%55.47M | 320.26%152.08M | 1,099.15%124.28M | -51.41%-149.21M | 129.20%25.69M | -52.70%36.19M | 147.68%10.36M | -275.90%-98.55M | -158.93%-87.98M | 2,323.57%76.5M |
| Fair value change income | -1,045.71%-13.23M | -171.36%-116.84K | -101.41%-21.81K | 100.26%278.29K | 103.76%1.4M | 114.49%163.74K | 148.52%1.55M | -503.96%-107.32M | -3,171.53%-37.21M | -237.44%-1.13M |
| Invest income | 152.07%181.06M | 72.91%170.21M | 1,511.26%122.62M | 163.53%66.06M | 422.42%71.83M | 49.45%98.44M | 204.44%7.61M | -74.87%25.07M | -114.12%-22.28M | 980.88%65.87M |
| -Including: Investment income associates | 176.08%32.63M | 211.32%19.55M | 184.38%13.39M | 61.68%-60.37M | 26.24%-42.89M | 1.10%-17.56M | -97.22%-15.87M | -108.01%-157.55M | -163.05%-58.15M | -1,765.89%-17.76M |
| Asset deal income | 111.71%1.74M | 324.21%2.68M | -100.05%-7.15K | -2,214.55%-11.49M | -2,840.68%-14.83M | -123.61%-1.2M | 497.33%15.28M | 97.59%-496.47K | -101.90%-504.44K | -67.43%5.07M |
| Other revenue | 19.68%87.78M | 34.58%72.37M | 54.75%36.17M | 4.20%104.95M | -7.77%73.34M | 6.50%53.77M | 38.20%23.37M | -13.76%100.71M | 4.85%79.52M | -12.85%50.49M |
| Operating profit | -0.86%606.42M | -8.31%488.07M | -7.74%272.88M | -86.89%89.44M | 24.61%611.66M | 29.69%532.29M | 62.86%295.76M | -2.51%682.48M | -21.97%490.84M | 6.10%410.42M |
| Add:Non operating Income | 557.04%6.33M | 171.68%2.25M | 424.68%263.4K | -79.68%1.72M | -80.15%962.83K | -78.53%828.94K | -98.33%50.2K | -59.01%8.47M | -71.31%4.85M | -28.79%3.86M |
| Less:Non operating expense | -85.31%7.23M | -90.00%4.76M | 1,436.31%2.56M | 2,211.81%174.03M | 509.23%49.23M | 652.58%47.58M | -78.99%166.33K | -90.17%7.53M | -9.49%8.08M | 33.53%6.32M |
| Total profit | 7.48%605.52M | 0.01%485.56M | -8.48%270.59M | -112.13%-82.87M | 15.54%563.39M | 19.01%485.53M | 60.84%295.65M | 6.09%683.42M | -23.46%487.61M | 5.27%407.96M |
| Less:Income tax cost | -9.46%95.24M | -26.06%51.53M | -55.21%24.24M | -92.64%14.15M | -29.57%105.19M | -21.33%69.7M | 13.10%54.11M | 43.90%192.19M | 86.79%149.36M | 84.92%88.59M |
| Net profit | 11.37%510.29M | 4.38%434.03M | 1.99%246.35M | -119.75%-97.01M | 35.46%458.2M | 30.21%415.83M | 77.63%241.53M | -3.80%491.23M | -39.28%338.25M | -5.96%319.37M |
| Net profit from continuing operation | 11.37%510.29M | 4.38%434.03M | 1.99%246.35M | -119.75%-97.01M | 35.46%458.2M | 30.21%415.83M | 77.63%241.53M | -3.80%491.23M | -39.28%338.25M | -5.96%319.37M |
| Less:Minority Profit | -131.79%-5.03M | -110.36%-1.21M | -123.62%-2.18M | -261.88%-3.84M | 123.20%15.82M | 3,141.79%11.7M | 996.00%9.23M | -90.00%2.37M | -87.70%7.09M | -99.39%360.77K |
| Net profit of parent company owners | 16.49%515.31M | 7.70%435.24M | 6.99%248.53M | -119.06%-93.17M | 33.58%442.38M | 26.69%404.14M | 71.91%232.3M | 0.40%488.86M | -33.70%331.16M | 13.88%319.01M |
| Earning per share | ||||||||||
| Basic earning per share | 15.79%0.44 | 5.71%0.37 | 10.53%0.21 | -119.05%-0.08 | 35.71%0.38 | 29.63%0.35 | 72.73%0.19 | -2.33%0.42 | -36.79%0.28 | 6.30%0.27 |
| Diluted earning per share | 15.79%0.44 | 15.63%0.37 | 23.53%0.21 | -119.05%-0.08 | 35.71%0.38 | 23.08%0.32 | 54.55%0.17 | -2.33%0.42 | -35.19%0.28 | 4.00%0.26 |
| Other composite income | -124.64%-512.37K | -134.21%-1.08M | 48.35%-717.31K | -87.62%1.31M | -83.61%2.08M | -50.38%3.17M | -952.74%-1.39M | 422.99%10.59M | 351.69%12.69M | 61.92%6.38M |
| Other composite income of parent company owners | -124.64%-512.37K | -134.21%-1.08M | 48.35%-717.31K | -87.62%1.31M | -83.61%2.08M | -50.38%3.17M | -952.74%-1.39M | 422.99%10.59M | 351.69%12.69M | 61.92%6.38M |
| Total composite income | 10.75%509.77M | 3.33%432.95M | 2.29%245.63M | -119.07%-95.7M | 31.16%460.28M | 28.63%419M | 76.40%240.14M | -1.09%501.83M | -36.43%350.94M | -5.18%325.75M |
| Total composite income of parent company owners | 15.83%514.8M | 6.59%434.16M | 7.32%247.81M | -118.39%-91.86M | 29.26%444.46M | 25.18%407.3M | 70.68%230.91M | 3.28%499.45M | -30.45%343.85M | 14.54%325.39M |
| Total composite income of minority owners | -131.79%-5.03M | -110.36%-1.21M | -123.62%-2.18M | -261.88%-3.84M | 123.20%15.82M | 3,141.79%11.7M | 996.00%9.23M | -90.00%2.37M | -87.70%7.09M | -99.39%360.77K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
